Graduation Date

Summer 8-15-2025

Document Type

Thesis

Degree Name

Master of Science (MS)

Programs

Biochemistry & Molecular Biology

First Advisor

Mohan Kumar Krishan PhD

Abstract

Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease primarily affecting premature infants. The high mortality rate, ranging from 20-50%, mandates new therapeutic targets and treatment strategies. The present study demonstrates that TNBS (2,4,6-trinitrobenzenesulfonic acid) induced NEC-like injury is associated with the requirement of monocytes in the neonatal intestine with expressing TREM-1 (Triggering Receptor Expressed on Myeloid Cells-1). Consistent with the elevated expression of TREM-1 on monocytes, we notably found higher iFABP (intestinal fatty acid binding protein) expression, intestinal injury, and elevated inflammatory cytokines. Similarly, surgically removed intestinal specimens from human patients with NEC, we found CD14+ monocytes co-localized with TREM-1. Inhibition of TREM-1 by LP17 (LQVTDSGLYRCVIYHPP, an inhibitory peptide), in lipopolysaccharide-treated murine macrophage (RAW 264.7) cells showed decreased inflammatory cytokine production when compared to the vehicle controls. Furthermore, the administration of LP17 to NEC-like injured mice was found to reduce the intestinal injury, inflammatory response, and improve survival by inhibiting TREM1. These findings provide valuable information that TREM-1 could constitute a new therapeutic target during NEC.

Comments

2025 Copyright, the authors

Rights

The author holds the copyright to this work and any reuse or permissions must be obtained from the author directly.

Download

Available for download on Saturday, July 31, 2027

Share

COinS